封面
市场调查报告书
商品编码
1826808

2025年全球近视治疗市场报告

Myopia Treatment Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,近视治疗市场规模强劲成长,从2024年的178.2亿美元增加至2025年的195.2亿美元,复合年增长率达9.6%。这段时期的成长可归因于老年人口的成长、政府宣传计画的加强、近视治疗意识的增强、研发投入的增加以及远视视力障碍发病率的上升。

预计未来几年近视治疗市场规模将强劲成长,到2029年将达到279亿美元,复合年增长率为9.3%。预测期内的成长归因于远视力障碍发病率的上升、数位管道使用率的提高、医疗基础设施的完善、近视发病率的上升以及视力丧失病例的增加。预测期内的主要趋势包括硬式高透氧隐形眼镜的普及、光治疗方法的进步、遗传因素研究、数位平台和应用程式的普及以及阿托品眼药水的研发。

近视治疗包括旨在治疗或控制近视(俗称近视)的医疗或矫正方法。这种屈光不正会导致远处物体模糊,而近处物体清晰。近视治疗的主要目标是透过矫正屈光不正来改善视力和生活品质。它还致力于减缓近视的发展,从而减少对矫正镜片的长期依赖,并实现更好的视觉健康。

近视的主要治疗类别为单纯性近视、高度近视和病理性近视。单纯性近视是由于眼球过长或角膜过度弯曲引起的,导致远距离视力模糊,可以透过矫正镜片或屈光矫正手术治疗。治疗方法包括框架眼镜、隐形眼镜、屈光矫正手术、雷射辅助切除术(LASIK)、屈光切除术(PRK) 和角膜塑形术 (Ortho-K)。这些治疗透过各种方式进行,包括口服和非口服。分销管道包括直销和零售,面向医院、临床实验室、诊所和参考实验室等最终用户。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响,尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨,其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘,导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外,原料和零件的关税扰乱了关键药品和医疗设备的生产,造成供应链延迟。作为应对措施,该行业正在采用多样化的筹资策略,尽可能扩大本地生产,并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供近视治疗市场统计数据,例如全球市场规模、区域份额、近视治疗市场份额的竞争对手、近视治疗市场细分、市场趋势以及近视治疗行业的商机。本近视治疗市场研究报告对产业现状和未来趋势进行了详细分析,为您提供所需的全方位观点。

未来五年9.3%的成长预测比我们先前的预测略有下降0.2个百分点。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能会扰乱美国的儿童眼科护理,因为这会增加新加坡和法国研发的阿托品眼药水和近视预防眼镜的成本,加速视力丧失,并增加长期眼科护理成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,贸易摩擦的影响可能会更加广泛。

预计萤幕时间的增加将推动近视治疗市场的成长。萤幕时间是指个人使用配备萤幕的装置(例如智慧型手机、平板电脑、电脑和电视)的时间。推动这一成长的因素包括串流媒体服务、社群媒体平台、远距工作和虚拟会议的日益普及。近视治疗有助于缓解长时间萤幕时间引起的眼睛疲劳和不适,并提高视觉清晰度、焦点和整体舒适度。例如,美国疾病管制与预防中心 (CDC) 2024 年 10 月的数据显示,在 2021 年 7 月至 2023 年 12 月期间,50.4% 的 12 至 17 岁青少年报告每天在萤幕上花费 4 小时或更长时间。此外,22.8% 的人每天在萤幕上花费 3 小时,17.8% 的人花费 2 小时,6.1% 的人花费 1 小时,3.0% 的人花费不到 1 小时。这些萤幕时间趋势是推动近视治疗市场扩张的关键因素。

近视治疗市场的主要企业正致力于开发创新产品,例如光学生物计,以提高诊断准确性并提供个人化治疗。光学生物计使用光来评估眼部参数,例如轴长和角膜曲率,有助于诊断和监测眼科疾病。例如,2023 年 2 月,日本眼科产品专家 Nidec Corporation 推出了 AL-Scan M 和 MV-1 仪器。 AL-Scan M 具有 3D 自动追踪和自动拍摄功能,可实现与自动验光仪类似的高效且使用者友好的测量。这些增强功能提高了患者的吞吐量,特别是对于年轻患者。 AL-Scan M 旨在精确测量轴长,这对于追踪近视进展至关重要。此外,它与 MV-1 Myopia Viewer 软体无缝集成,便于追踪治疗历史和患者行为。

2023年1月,美国软式隐形眼镜製造商CooperVision收购了SynergEyes, Inc.,收购金额未揭露。此次收购旨在增强CooperVision的专业隐形眼镜产品组合,并巩固其在高端眼科护理市场的地位。 SynergEyes, Inc.总部位于美国,专门生产旨在应对近视加深的隐形眼镜。

近视治疗市场由提供近视预防计划、视力治疗以及生活方式和行为指导等服务的营业单位所赚取的收益构成。市场价值还包括服务提供者销售或包含在其服务产品中的相关产品的价值。近视治疗市场包括处方眼镜、阿托品眼药水和近视控制眼镜的销售。该市场的价值是指“出厂价”,即商品製造商或创造者销售的商​​品价值,无论是出售给其他营业单位(包括下游製造商、经销商和零售商)或直接出售给最终客户。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、贸易战和关税,以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球近视治疗:PESTEL分析(政治、社会、科技、环境、法律因素、驱动因素与限制因素)
  • 最终用途产业分析
  • 全球近视治疗市场:成长率分析
  • 全球近视治疗市场表现:规模与成长,2019-2024
  • 全球近视治疗市场预测:2024-2029年、2034年规模与成长
  • 全球近视治疗:总潜在市场(TAM)

第六章 市场细分

  • 全球近视治疗市场类型、绩效及预测(2019-2024、2024-2029、2034)
  • 单纯性近视
  • 严重近视
  • 病理性近视
  • 全球近视治疗市场:按治疗、表现和预测,2019-2024 年、2024-2029 年、2034 年
  • 眼镜
  • 隐形眼镜
  • 屈光矫正手术
  • 雷射诱导眼内骨骼和屈光矫正手术(LASIK)
  • 屈光切除术(PRK)
  • 角膜塑形术(角膜塑形)
  • 全球近视治疗市场(依给药途径):2019-2024 年、2024-2029 年、2034 年表现与预测
  • 口服
  • 肠外
  • 其他给药途径
  • 全球近视治疗市场(依通路):2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 直接竞标
  • 零售
  • 其他分销管道
  • 全球近视治疗市场(按最终用户、业绩和预测),2019-2024 年、2024-2029 年、2034 年
  • 医院或临床实验室
  • 医生诊所
  • 参考实验室
  • 其他最终用户
  • 全球近视治疗市场:依单纯近视类型细分、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 轻度近视
  • 中度近视
  • 全球近视治疗市场:依高度近视类型细分、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 严重近视
  • 高度近视
  • 全球近视治疗市场:依病理性近视类型细分、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 退化性近视
  • 恶性近视

第七章 区域和国家分析

  • 全球近视治疗市场:依地区、绩效及预测,2019-2024年、2024-2029年、2034年
  • 全球近视治疗市场:依国家、绩效及预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第18章:法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章:俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章:竞争格局与公司概况

  • 近视治疗市场:竞争格局
  • 近视治疗市场:公司简介
    • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • CooperVision Inc.
  • Menicon Co. Ltd.
  • Topcon Healthcare Inc.
  • Essilor Ltd.
  • NIDEK CO. LTD.
  • SightGlass Vision Inc.
  • SCHWIND eye-tech-solutions GmbH
  • Visioneering Technologies Inc.
  • MEDMONT INTERNATIONAL PTY LTD.
  • Vyluma Inc.
  • Haag-Streit Holding AG
  • NovaSight Ltd.
  • Euclid Vision Corporation
  • Treehouse Eyes LLC
  • Sydnexis Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章:高潜力市场国家、细分市场与策略

  • 2029年近视治疗市场:提供新机会的国家
  • 2029年近视治疗市场:细分领域带来新机会
  • 2029年近视治疗市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33822u

Myopia treatment involves medical or corrective methods designed to address or manage myopia, commonly known as nearsightedness. This refractive error causes distant objects to appear blurry while nearby objects remain clear. The primary aim of myopia treatment is to enhance vision and improve quality of life by correcting refractive errors. Additionally, it focuses on controlling the progression of myopia, thereby reducing long-term dependence on corrective lenses for better vision health.

The primary categories of myopia treated include simple myopia, high myopia, and pathological myopia. Simple myopia, caused by an elongated eyeball or an overly curved cornea, results in blurry distant vision and can be treated with corrective lenses or refractive surgery. Treatment options include eyeglasses, contact lenses, refractive surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and orthokeratology (Ortho-K). These treatments are administered through various methods, such as oral or parenteral routes, among others. Distribution channels include direct tender and retail sales, catering to end users such as hospitals, clinical laboratories, physician offices, and reference laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The myopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia treatment market statistics, including the myopia treatment industry global market size, regional shares, competitors with the myopia treatment market share, detailed myopia treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the myopia treatment industry. This myopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myopia treatment market size has grown strongly in recent years. It will grow from $17.82 billion in 2024 to $19.52 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to an increase in the geriatric population, increasing government awareness programs, increasing awareness of myopia treatment, increasing investment in research and development, and rising incidence of distance vision impairment.

The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $27.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the increasing occurrence of distance vision impairment, increasing use of digital channels, rising healthcare infrastructure, rising incidence of myopia, and increasing cases of vision loss. Major trends in the forecast period include the adoption of rigid gas-permeable contact lenses, advancement in light-based therapies, cutting-edge research investigating the genetic factors, the adoption of digital platforms and apps, and development in atropine eye drops.

The forecast of 9.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pediatric ophthalmology by inflating prices of atropine eye drops and myopia control spectacles developed in Singapore and France, resulting in progressive vision deterioration and higher long-term eye care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the myopia treatment market is anticipated to be driven by the rising levels of screen time. Screen time refers to the duration individuals spend using devices equipped with screens, such as smartphones, tablets, computers, and televisions. Factors contributing to this increase include the growing popularity of streaming services, social media platforms, remote work, and virtual meetings. Myopia treatments are beneficial in mitigating eye strain and discomfort caused by extended screen use, enhancing visual clarity, focus, and overall comfort. For example, in October 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based government agency, revealed that between July 2021 and December 2023, 50.4% of teenagers aged 12-17 reported spending four or more hours daily on screens. Additionally, 22.8% spent three hours, 17.8% spent two hours, 6.1% spent one hour, and 3.0% spent less than one hour per day on screens. This growing screen time trend is a significant factor fueling the expansion of the myopia treatment market.

Leading companies in the myopia treatment market are concentrating on developing innovative products, such as optical biometers, to improve diagnostic accuracy and provide personalized treatments. Optical biometers utilize light to assess eye parameters such as axial length and corneal curvature, aiding in the diagnosis and monitoring of eye conditions. For example, in February 2023, NIDEK Co., Ltd., a Japanese company specializing in ophthalmic products, introduced the AL-Scan M and MV-1 devices. The AL-Scan M features 3D auto-tracking and auto-shot capabilities, allowing for efficient and user-friendly measurements similar to those of an autorefractor. These enhancements boost patient throughput, especially for younger patients. The AL-Scan M is designed for precise axial length measurements, which are vital for tracking myopia progression. Additionally, it integrates smoothly with the MV-1 Myopia Viewer software, facilitating the tracking of treatment history and patient behavior.

In January 2023, CooperVision, Inc., a US-based producer of soft contact lenses, acquired SynergEyes, Inc. for an undisclosed sum. This acquisition is intended to bolster CooperVision's specialty contact lens portfolio and reinforce its standing in the advanced ocular care market. SynergEyes, Inc., also based in the US, specializes in manufacturing contact lenses designed to address myopia progression.

Major players in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.

Asia Pacific was the largest region in the myopia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myopia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the myopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia treatment market consists of revenues earned by entities by providing services such as myopia control programs, vision therapy, and lifestyle and behavioral guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The myopia treatment market includes sales of prescription glasses, atropine drops, and myopia control glasses. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Simple Myopia; High Myopia; Pathological Myopia
  • 2) By Treatment: Eyeglasses; Contact Lenses; Refractive Surgery; Laser-Assisted In Situ Keratomileusis (LASIK); Photorefractive Keratectomy (PRK); Orthokeratology (Ortho-K)
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
  • 4) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
  • 5) By End-User: Hospital Or Clinical Laboratories; Physician Offices; Reference Laboratories; Other End-Users
  • Subsegments:
  • 1) By Simple Myopia: Mild Myopia; Moderate Myopia
  • 2) By High Myopia: Severe Myopia; Very Severe Myopia
  • 3) By Pathological Myopia: Degenerative Myopia; Malignant Myopia
  • Companies Mentioned: Regeneron Pharmaceuticals Inc.; Alcon Inc.; Bausch Health Companies Inc.; Hoya Corporation; Johnson & Johnson Vision Care Inc.; CooperVision Inc.; Menicon Co. Ltd.; Topcon Healthcare Inc.; Essilor Ltd.; NIDEK CO. LTD.; SightGlass Vision Inc.; SCHWIND eye-tech-solutions GmbH; Visioneering Technologies Inc.; MEDMONT INTERNATIONAL PTY LTD.; Vyluma Inc.; Haag-Streit Holding AG; NovaSight Ltd.; Euclid Vision Corporation; Treehouse Eyes LLC; Sydnexis Inc.; Neurobit Technologies Co. Ltd.; Kubota Pharmaceutical Holdings Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myopia Treatment Market Characteristics

3. Myopia Treatment Market Trends And Strategies

4. Myopia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Myopia Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Myopia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Myopia Treatment Market Growth Rate Analysis
  • 5.4. Global Myopia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Myopia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Myopia Treatment Total Addressable Market (TAM)

6. Myopia Treatment Market Segmentation

  • 6.1. Global Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Myopia
  • High Myopia
  • Pathological Myopia
  • 6.2. Global Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Eyeglasses
  • Contact Lenses
  • Refractive Surgery
  • Laser-Assisted In Situ Keratomileusis (LASIK)
  • Photorefractive Keratectomy (PRK)
  • Orthokeratology (Ortho-K)
  • 6.3. Global Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.4. Global Myopia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tender
  • Retail Sales
  • Other Distribution Channels
  • 6.5. Global Myopia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Or Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End-Users
  • 6.6. Global Myopia Treatment Market, Sub-Segmentation Of Simple Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mild Myopia
  • Moderate Myopia
  • 6.7. Global Myopia Treatment Market, Sub-Segmentation Of High Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Severe Myopia
  • Very Severe Myopia
  • 6.8. Global Myopia Treatment Market, Sub-Segmentation Of Pathological Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Degenerative Myopia
  • Malignant Myopia

7. Myopia Treatment Market Regional And Country Analysis

  • 7.1. Global Myopia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Myopia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myopia Treatment Market

  • 8.1. Asia-Pacific Myopia Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myopia Treatment Market

  • 9.1. China Myopia Treatment Market Overview
  • 9.2. China Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myopia Treatment Market

  • 10.1. India Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myopia Treatment Market

  • 11.1. Japan Myopia Treatment Market Overview
  • 11.2. Japan Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myopia Treatment Market

  • 12.1. Australia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myopia Treatment Market

  • 13.1. Indonesia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myopia Treatment Market

  • 14.1. South Korea Myopia Treatment Market Overview
  • 14.2. South Korea Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myopia Treatment Market

  • 15.1. Western Europe Myopia Treatment Market Overview
  • 15.2. Western Europe Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myopia Treatment Market

  • 16.1. UK Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myopia Treatment Market

  • 17.1. Germany Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myopia Treatment Market

  • 18.1. France Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myopia Treatment Market

  • 19.1. Italy Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myopia Treatment Market

  • 20.1. Spain Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myopia Treatment Market

  • 21.1. Eastern Europe Myopia Treatment Market Overview
  • 21.2. Eastern Europe Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myopia Treatment Market

  • 22.1. Russia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myopia Treatment Market

  • 23.1. North America Myopia Treatment Market Overview
  • 23.2. North America Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myopia Treatment Market

  • 24.1. USA Myopia Treatment Market Overview
  • 24.2. USA Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myopia Treatment Market

  • 25.1. Canada Myopia Treatment Market Overview
  • 25.2. Canada Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myopia Treatment Market

  • 26.1. South America Myopia Treatment Market Overview
  • 26.2. South America Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myopia Treatment Market

  • 27.1. Brazil Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myopia Treatment Market

  • 28.1. Middle East Myopia Treatment Market Overview
  • 28.2. Middle East Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myopia Treatment Market

  • 29.1. Africa Myopia Treatment Market Overview
  • 29.2. Africa Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myopia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Myopia Treatment Market Competitive Landscape
  • 30.2. Myopia Treatment Market Company Profiles
    • 30.2.1. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Myopia Treatment Market Other Major And Innovative Companies

  • 31.1. CooperVision Inc.
  • 31.2. Menicon Co. Ltd.
  • 31.3. Topcon Healthcare Inc.
  • 31.4. Essilor Ltd.
  • 31.5. NIDEK CO. LTD.
  • 31.6. SightGlass Vision Inc.
  • 31.7. SCHWIND eye-tech-solutions GmbH
  • 31.8. Visioneering Technologies Inc.
  • 31.9. MEDMONT INTERNATIONAL PTY LTD.
  • 31.10. Vyluma Inc.
  • 31.11. Haag-Streit Holding AG
  • 31.12. NovaSight Ltd.
  • 31.13. Euclid Vision Corporation
  • 31.14. Treehouse Eyes LLC
  • 31.15. Sydnexis Inc.

32. Global Myopia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myopia Treatment Market

34. Recent Developments In The Myopia Treatment Market

35. Myopia Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Myopia Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Myopia Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Myopia Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer